NewsRx

Search our medical news database

Idera Pharmaceuticals, Inc.

Idera Pharmaceuticals to Present at Annual BIO CEO & Investor Conference 2009

Published in Healthcare Mergers, Acquisitions and Ventures Week, February 14th, 2009

Idera Pharmaceuticals, Inc. (Nasdaq: IDRA), a biotechnology company engaged in the discovery and development of DNA- and RNA-based drug candidates targeted to Toll-like Receptors (TLR), announced that it will present a corporate overview at the 11th Annual BIO CEO & Investor Conference on Monday, February 9 at 10:30 a.m. (ET) at the Waldorf=Astoria hotel in New York City.

The presentation will be available via live audio webcast on the Company’s website at www.iderapharma.com. Archived replays will also be located on the Company’s site following the event. About Idera Pharmaceuticals, Inc. Idera Pharmaceuticals develops drug candidates to treat infectious diseases,...

Want to see the full article?

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Buy Now



NewsRx is Social

Follow us on your favorite social network by clicking on a button below:

Follow NewsRx on Twitter

NewsRx on Facebook

Awards

eHealthcare Leadership 2011 Winner
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

  • Google 2010 PageRank: #2 Among Top Health News and Media Publications
  • Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
  • Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
  • Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
NewsRx on Facebook